Skip to Main Content

Paper Details

Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non-SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real-world meta-analysis of 4 observational databases (OBSERVE-4D).
Diabetes Obes Metab
130
2018
BKLE, HHF, SGLT2, SGLT2i, Sodium, Sodium glucose, Sodium glucose co-transporter 2, T2DM, amputation, below-knee lower extremity (BKLE) amputation, canagliflozin, cardiovascular disease, glucose, heart failure, patients, type 2 diabetes mellitus

Datasets

Release 1.2